---
layout: post
title: 'USAN Watch: April 2013'
date: '2013-04-05T09:50:00.003+01:00'
author: John Overington
tags:
- INNS and USANS
modified_time: '2013-04-25T08:56:05.991+01:00'
thumbnail: http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s72-c/inns+and+usans.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-330279883420958284
blogger_orig_url: http://chembl.blogspot.com/2013/04/usan-watch-april-2013.html
---

<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png"><img border="0" src="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png" /></a></div>
<span class="Apple-style-span" style="font-family: inherit;">The USANs for April 2013 have recently been published.</span><br />
<table border="1"><tbody>
<tr><td><b><span class="Apple-style-span" style="font-family: inherit;">USAN </span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Research Code </span></b></td><td><b>InChIKey (Parent)</b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Drug Class</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Therapeutic class</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Target</span></b></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/aftobetin.pdf">aftobetin</a>, <a href="http://www.ama-assn.org/resources/doc/usan/aftobetin-hydrochloride.pdf">aftobetin hydrochloride</a></td><td>ANCA-11, NCE-11</td><td></td><td>synthetic small molecule</td><td>imaging agent</td><td>n/a</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/anifrolumab.pdf">anifrolumab</a></td><td>MEDI-546</td><td>n/a</td><td>mAb</td><td>therapeutic</td><td>interferon a/b receptor</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/cobimetinib-fumarate.pdf">cobimetinib fumarate</a></td><td>RG-7420, GDC-0973, XL-518</td><td></td><td>synthetic small molecule</td><td>therapeutic</td><td>MEK</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/doravirine.pdf">doravirine</a></td><td>MK-1439</td><td></td><td>synthetic small molecule</td><td>therapeutic</td><td>HIV-1 RT</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/lambrolizumab.pdf">lambrolizumab</a></td><td>MK-3475</td><td>n/a</td><td>mAb</td><td>therapeutic</td><td>PDCD-1</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/pelareorep.pdf">pelareorep</a></td><td>Reolysin, PO-BB-0209</td><td>n/a</td><td>virus</td><td>therapeutic</td><td>n/a</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/plazomicin-sulfate.pdf">plazomicin sulfate</a></td><td>ACHN-490</td><td></td><td>natural product derived small molecule</td><td>therapeutic</td><td>30S ribosome</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/ralimetinib.pdf">ralimetinib</a>, <a href="http://www.ama-assn.org/resources/doc/usan/ralimetinib-mesylate.pdf">ralimetinib mesylate</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">LY-2228820&nbsp;</span></span></div>
</div>
</div>
</td><td></td><td><span style="font-family: inherit;">synthetic small molecule</span></td><td><span style="font-family: inherit;">therapeutic</span></td><td><span style="font-family: inherit;">MAPK14</span></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/ricolinostat.pdf"><span style="font-family: inherit;">ricolinostat</span></a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">ACY-1215, ACY-63&nbsp;</span></span></div>
</div>
</div>
</td><td></td><td>synthetic small molecule</td><td>therapeutic</td><td>HDAC</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/ubrogepant.pdf">ubrogepant</a></td><td>MK-1602</td><td></td><td>synthetic small molecule</td><td>therapeutic</td><td>CGRP</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/valbenazine.pdf">valbenazine</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">NBI-98854&nbsp;</span></span></div>
</div>
</div>
</td><td></td><td>synthetic small molecule</td><td>therapeutic</td><td>VMAT2</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/velcalcetide-hydrochloride.pdf">velcalcetide hydrochloride</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">KAI-4169&nbsp;</span></span></div>
</div>
</div>
</td><td>n/a</td><td>peptide</td><td>therapeutic</td><td>CaSr</td></tr>
</tbody></table>
